The Cooper Companies, Inc. (FRA:CP60)

Revenue

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015	Oct 31, 2014	Oct 31, 2013
Toric and Multifocal Revenue	1.35B
Sphere, Other Revenue	1.39B
Total CooperVision Revenue	2.74B
Office and Surgical Products Revenue	824.00M
Fertility Revenue	524.60M
Total CooperSurgical Revenue	1.35B
Revenue (Other)	-2.74B
Revenue (Total)	4.09B

Revenue by Geography

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015	Oct 31, 2014	Oct 31, 2013
United States Revenue	2.05B
Europe Revenue	1.25B
Rest Of The World Revenue	785.20M
Revenue (Total)	4.09B

EBIT

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015	Oct 31, 2014	Oct 31, 2013
CooperVision Operating Income	729.60M
CooperSurgical Operating Income	43.40M
Corporate Operating Income	-90.10M
Operating Income (Total)	682.90M

Key Performance Indicators

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016	Oct 31, 2015	Oct 31, 2014	Oct 31, 2013
CooperVision - Constant Currency Revenue Growth	5.00%
CooperSurgical - Constant Currency Revenue Growth	5.00%
Total Company - Constant Currency Revenue Growth	5.00%
CooperVision - Organic Revenue Growth	5.00%
CooperSurgical - Organic Revenue Growth	3.00%
Total Company - Organic Revenue Growth	4.00%

Updated Oct 31, 2025. Data Source: Fiscal.ai.